FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kenneth Offit

Research Profile

Physiology

Disorders

Genes & Molecular Sequences

Chemicals & Drugs

Living Beings

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Susan M Domchek; Judy E Garber; Kenneth Offit; Angela Bradbury; Mark Robson
Multiplex genetic testing for cancer susceptibility: out on the high wire without a net?
Susan M Domchek; Laura Goldstein; Clifford Hudis; Komal Jhaveri; Noah D Kauff; mustafa khasraw; Katherine L Nathanson; Kenneth Offit; Sujata Patil; Jacquelyn Powers; Zsofia Stadler; Jill Stopfer; Mark Robson
Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer.
Shaheen Alanee; Rajmohan Murali; Rohini Rau-Murthy; Kasmintan A Schrader; Sohela Shah; Kenneth Offit
Absence of loss of heterozygosity of BRCA1 in a renal tumor from a BRCA1 germline mutation carrier.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kenneth Offit (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Susan M Domchek; Judy E Garber; Kenneth Offit; Angela Bradbury; Mark Robson
Multiplex genetic testing for cancer susceptibility: out on the high wire without a net?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(10):1267-70.
2013: Susan M Domchek; Laura Goldstein; Clifford Hudis; Komal Jhaveri; Noah D Kauff; mustafa khasraw; Katherine L Nathanson; Kenneth Offit; Sujata Patil; Jacquelyn Powers; Zsofia Stadler; Jill Stopfer; Mark Robson
Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer.
Cancer 2013;119(7):1344-8.
2013: Shaheen Alanee; Rajmohan Murali; Rohini Rau-Murthy; Kasmintan A Schrader; Sohela Shah; Kenneth Offit
Absence of loss of heterozygosity of BRCA1 in a renal tumor from a BRCA1 germline mutation carrier.
Familial cancer 2013;12(1):125-7.
2013: Joseph Vijai; Andrew Zelenetz; Liying Zhang; Dina Ben-Yehuda; Jennifer Brown; Srujana Cheguri; Ana Virginia Dutra-Clarke; Nichole Hansen; Tomas Kirchhoff; Robert J Klein; Mortimer Lacher; Steven M Lipkin; Christopher Manschreck; Ora Paltiel; Carol Portlock; Jennifer Przybylo; Rohini Rau-Murthy; Mark Robson; Kara Sarrel; Kasmintan A Schrader; Sohela Shah; Zsofia Kinga Stadler; David J Straus; Agnes Viale; Kenneth Offit
Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies.
PLoS genetics 2013;9(1):e1003220.
2012: Karen Hurley; Noah D Kauff; Yelena Kemel; Aliza Phillips; Lisa R Rubin; Michal Sagi; Rikki Stern; Allison Werner-Lin; Ina Cholst; Kenneth Offit
Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations: a qualitative study of patient preferences.
Cancer 2012;118(24):6270-7.
2012: Zsofia Kinga Stadler; Martin Weiser; Liying Zhang; Jinru Shia; Ruben Bacares; Daniel G Coit; Kenneth Offit; Derek G Power; Mark Robson; Erin Salo-Mullen; Mark Schattner
Juvenile polyposis syndrome presenting with familial gastric cancer and massive gastric polyposis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(25):e229-32.
2012: Zsofia Kinga Stadler; Joseph Vijai; Michael Wigler; Boris Yamrom; Rohini Rau-Murthy; Mark Robson; Michael Ronemus; Kara Sarrel; Kasmintan Schrader; Sohela Shah; Joel Sheinfeld; George Bosl; Diane Esposito; Darren Feldman; Nichole Hansen; Noah D Kauff; Jude Kendall; Robert J Klein; Yoon-Ha Lee; Anthony Leotta; Dan Levy; Steven M Lipkin; Rajmohan Murali; Larry Norton; Kenneth Offit
Rare de novo germline copy-number variation in testicular cancer.
American journal of human genetics 2012;91(2):379-83.
2012: David M Hyman; Alexia Iasonos; Carol Aghajanian; Angela G Arnold; Richard R Barakat; Jasmine Bhatia; Rachel N Grisham; Douglas A Levine; Kenneth Offit; Mary F Phillips; David R Spriggs; Qin Zhou; Noah D Kauff
Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer.
Cancer 2012;118(15):3703-9.
2012: Kasmintan Schrader; Kenneth Offit; Zsofia Kinga Stadler
Genetic testing in gastrointestinal cancers: a case-based approach.
Oncology (Williston Park, N.Y.) 2012;26(5):433-6, 438, 444-6 passim.
2012: Yael Laitman; Lesley McGuffog; Katherine L Nathanson; Susan L Neuhausen; Heli Nevanlinna; Kenneth Offit; Susan Peock; Paolo Peterlongo; Paolo Radice; Johanna Rantala; Rita K Schmutzler; Olga M Sinilnikova; Barbara Wappenschmidt; Ido Wolf; Antonis C Antoniou; Adalgeir Arason; Maria Adelaide Caligo; Xiaoqing Chen; Georgia Chenevix-Trench; Fergus Couch; Douglas F Easton; Patricia Ganz; Andrew K Godwin; Sue Healey; Frans B L Hogervorst; Claudine Isaacs; Tomas Kirchhoff; Karoline B Kuchenbaecker; Eitan Friedman
The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers.
Breast cancer research and treatment 2012;132(3):1119-26.
2012: David J Gallagher; Matthew I Milowsky; Michael J Morris; Kenneth Offit; Jasmine Bhatia; Angel M Cronin; James A Eastham; Peter T Scardino; Mark Robson
Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer.
BJU international 2012;109(5):713-9.
2011: Liying Zhang; Jeanine M Ruggeri; Joshua Somar; Zsofia Kinga Stadler; Ruben Bacares; Lishi Chen; Yelena Kemel; Kenneth Offit
BRCA1 R71K missense mutation contributes to cancer predisposition by increasing alternative transcript levels.
Breast cancer research and treatment 2011;130(3):1051-6.
2011: Thomas Wiesner; Christian Windpassinger; Ingrid Wolf; Peter Ulz; Agnes Viale; Werner Wackernagel; David Abramson; Boris C Bastian; Jürgen C Becker; Lorenzo Cerroni; Isabella Fried; Klaus G Griewank; Heinz Kutzner; Alex E Lash; Shea Loy; Rajmohan Murali; Anna C Obenauf; Kenneth Offit; Arthur Ott; Gabriele Palmedo; Mono Pirun; Arno Rütten; Nicholas D Socci; Michael R Speicher
Germline mutations in BAP1 predispose to melanocytic tumors.
Nature genetics 2011;43(10):1018-21.
2011: Virginia G Kaklamani; Christos Mantzoros; Carole Oddoux; Kenneth Offit; Harry Ostrer; Maureen Sadim; Nengjun Yi; Kui Zhang; Boris Pasche
Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk.
Metabolism: clinical and experimental 2011;60(9):1234-43.
2011: Zsofia Kinga Stadler; Liying Zhang; William D Foulkes; Robert Kurtz; Kenneth Offit; Sara H Olson; Mark Robson; Nelly Sabbaghian; Erin Salo-Mullen; Jennifer A Simon; Marc Tischkowitz
Germline PALB2 mutation analysis in breast-pancreas cancer families.
Journal of medical genetics 2011;48(8):523-5.
2011: E Comen; M Davids; Clifford Hudis; Tomas Kirchhoff; Kenneth Offit; Mark Robson
Relative contributions of BRCA1 and BRCA2 mutations to "triple-negative" breast cancer in Ashkenazi Women.
Breast cancer research and treatment 2011;129(1):185-90.
2011: Kenneth Offit
Personalized medicine: new genomics, old lessons.
Human genetics 2011;130(1):3-14.
2011: E Comen; L Balistreri; Mithat Gonen; A Dutra-Clarke; M Fazio; J Vijai; Zsofia Kinga Stadler; Noah D Kauff; Tomas Kirchhoff; Clifford Hudis; Kenneth Offit; Mark Robson
Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women.
Breast cancer research and treatment 2011;127(2):479-87.
2011: Semanti Mukherjee; Kenneth Offit; Sara H Olson; Irene Orlow; Jennifer Simon; Agnes Viale; Sarah Yoo; Sharon Bayuga; Robert C Kurtz; Emmy Ludwig; Robert J Klein
Including additional controls from public databases improves the power of a genome-wide association study.
Human heredity 2011;72(1):21-34.
2010: E Theodoratou; H Campbell; A Tenesa; R Houlston; E Webb; S Lubbe; P Broderick; S Gallinger; E M Croitoru; M A Jenkins; A K Win; S P Cleary; T Koessler; P D Pharoah; S Küry; S Bézieau; B Buecher; Nathan Ellis; P Peterlongo; Kenneth Offit; L A Aaltonen; S Enholm; A Lindblom; X-L Zhou; I P Tomlinson; V Moreno; I Blanco; G Capellà; R Barnetson; M E Porteous; M G Dunlop; S M Farrington
A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants.
British journal of cancer 2010;103(12):1875-84.
2010: Kenneth Offit; Mark Robson
New pharmacogenomic paradigm in breast cancer treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(31):4665-6.
2010: Mia M. Gaudet; Tomas Kirchhoff; Todd Green; Joseph Vijai; Joshua M Korn; Candace Guiducci; Ayellet V Segrè; Kate McGee; Lesley McGuffog; Christiana Kartsonaki; Jonathan Morrison; Sue Healey; Olga M Sinilnikova; Dominique Stoppa-Lyonnet; Sylvie Mazoyer; Marion Gauthier-Villars; Hagay Sobol; Michel Longy; Marc Frenay; Frans B L Hogervorst; Matti A Rookus; J Margriet Collée; Nicoline Hoogerbrugge; Kees E P van Roozendaal; Marion Piedmonte; Wendy Rubinstein; Stacy Nerenstone; Linda Van Le; Stephanie V Blank; Trinidad Caldés; Miguel de la Hoya; Heli Nevanlinna; Kristiina Aittomäki; Conxi Lazaro; Ignacio Blanco; Adalgeir Arason; Oskar T Johannsson; Rosa B Barkardottir; Peter Devilee; Olofunmilayo I Olopade; Susan L Neuhausen; Xianshu Wang; Zachary S Fredericksen; Paolo Peterlongo; Siranoush Manoukian; Monica Barile; Alessandra Viel; Paolo Radice; Catherine M Phelan; Steven Narod; Gad Rennert; Flavio Lejbkowicz; Anath Flugelman; Irene L Andrulis; Gord Glendon; Hilmi Ozcelik; Amanda E Toland; Marco Montagna; Emma D'Andrea; Eitan Friedman; Yael Laitman; Ake Borg; Mary Beattie; Susan J Ramus; Susan M Domchek; Katherine L Nathanson; Tim Rebbeck; Amanda B Spurdle; Xiaoqing Chen; Helene Holland; Esther M John; John L Hopper; Saundra S Buys; Mary B Daly; Melissa C Southey; Mary Beth Terry; Nadine Tung; Thomas V Overeem Hansen; Finn C Nielsen; Mark H Greene; Mark I Greene; Phuong L Mai; Ana Osorio; Mercedes Durán; Raquel Andres; Javier Benítez; Jeffrey N Weitzel; Judy Garber; Ute Hamann; Susan Peock; Margaret Cook; Clare Oliver; Debra Frost; Radka Platte; D Gareth Evans; Fiona Lalloo; Ros Eeles; Louise Izatt; Lisa Walker; Jacqueline Eason; Julian Barwell; Andrew K Godwin; Rita K Schmutzler; Barbara Wappenschmidt; Stefanie Engert; Norbert Arnold; Dorothea Gadzicki; Michael Dean; Bert Gold; Robert J. Klein; Fergus J Couch; Georgia Chenevix-Trench; Douglas F Easton; Mark J Daly; Antonis C Antoniou; David M Altshuler; Kenneth Offit
Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.
PLoS genetics 2010;6(10):e1001183.
2010: David J Gallagher; James D Smith; Kenneth Offit; Zsofia Kinga Stadler
Diagnosing hereditary colorectal cancer.
Clinical colorectal cancer 2010;9(4):205-11.
2010: Antonis C Antoniou; Xianshu Wang; Zachary S Fredericksen; Lesley McGuffog; Robert Tarrell; Olga M Sinilnikova; Sue Healey; Jonathan Morrison; Christiana Kartsonaki; Timothy Lesnick; Maya Ghoussaini; Daniel Barrowdale; Susan Peock; Margaret Cook; Clare Oliver; Debra Frost; Diana Eccles; D Gareth Evans; Ros Eeles; Louise Izatt; Carol Chu; Fiona Douglas; Joan Paterson; Dominique Stoppa-Lyonnet; Claude Houdayer; Sylvie Mazoyer; Sophie Giraud; Christine Lasset; Audrey Remenieras; Olivier Caron; Agnès Hardouin; Pascaline Berthet; Frans B L Hogervorst; Matti A Rookus; Agnes Jager; Ans van den Ouweland; Nicoline Hoogerbrugge; Rob B van der Luijt; Hanne Meijers-Heijboer; Encarna B Gómez García; Peter Devilee; Maaike P G Vreeswijk; Jan Lubinski; Anna Jakubowska; Jacek Gronwald; Tomasz Huzarski; Tomasz Byrski; Bohdan Górski; Cezary Cybulski; Amanda B Spurdle; Helene Holland; David E Goldgar; Esther M John; John L Hopper; Melissa Southey; Saundra S Buys; Mary B Daly; Mary-Beth Terry; Rita K Schmutzler; Barbara Wappenschmidt; Christoph Engel; Alfons Meindl; Sabine Preisler-Adams; Norbert Arnold; Dieter Niederacher; Christian Sutter; Susan M Domchek; Katherine L Nathanson; Timothy Rebbeck; Joanne L Blum; Marion Piedmonte; Gustavo Rodriguez; Katie Wakeley; John F Boggess; Jack Basil; Stephanie V Blank; Eitan Friedman; Bella Kaufman; Yael Laitman; Roni Milgrom; Irene L Andrulis; Gord Glendon; Hilmi Ozcelik; Tomas Kirchhoff; Joseph Vijai; Mia M. Gaudet; David Altshuler; Candace Guiducci; Niklas Loman; Katja Harbst; Johanna Rantala; Hans Ehrencrona; Anne-Marie Gerdes; Mads Thomassen; Lone Sunde; Paolo Peterlongo; Siranoush Manoukian; Bernardo Bonanni; Alessandra Viel; Paolo Radice; Trinidad Caldes; Miguel de la Hoya; Christian F Singer; Anneliese Fink-Retter; Mark H Greene; Phuong L Mai; Jennifer T Loud; Lucia Guidugli; Noralane Lindor; Thomas V O Hansen; Finn C Nielsen; Ignacio Blanco; Conxi Lazaro; Judy Garber; Susan J Ramus; Simon A Gayther; Catherine Phelan; Stephen Narod; Csilla I Szabo; Javier Benitez; Ana Osorio; Heli Nevanlinna; Tuomas Heikkinen; Maria A Caligo; Mary S Beattie; Ute Hamann; Andrew K Godwin; Marco Montagna; Cinzia Casella; Susan L Neuhausen; Beth Y Karlan; Nadine Tung; Amanda E Toland; Jeffrey Weitzel; Olofunmilayo Olopade; Jacques Simard; Penny Soucy; Wendy S Rubinstein; Adalgeir Arason; Gad Rennert; Nicholas G Martin; Grant W Montgomery; Jenny Chang-Claude; Dieter Flesch-Janys; Hiltrud Brauch; Gianluca Severi; Laura Baglietto; Angela Cox; Simon S Cross; Penelope Miron; Sue M Gerty; William Tapper; Drakoulis Yannoukakos; George Fountzilas; Peter A Fasching; Matthias W Beckmann; Isabel Dos Santos Silva; Julian Peto; Diether Lambrechts; Robert Paridaens; Thomas Rüdiger; Asta Försti; Robert Winqvist; Katri Pylkäs; Robert B Diasio; Adam M Lee; Jeanette Eckel-Passow; Celine Vachon; Fiona Blows; Kristy Driver; Alison Dunning; Paul P D Pharoah; Kenneth Offit; V Shane Pankratz; Hakon Hakonarson; Georgia Chenevix-Trench; Douglas F Easton; Fergus J Couch
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population.
Nature genetics 2010;42(10):885-92.
2010: Zsofia Kinga Stadler; Joseph Vijai; Peter Thom; Tomas Kirchhoff; Nichole A L Hansen; Noah D Kauff; Mark Robson; Kenneth Offit
Genome-wide association studies of cancer predisposition.
Hematology/oncology clinics of North America 2010;24(5):973-96.
2010: Mark Robson; Kenneth Offit
Inherited predisposition to cancer: introduction and overview.
Hematology/oncology clinics of North America 2010;24(5):793-7.
2010: Kenneth Offit; Mark Robson
Genetic predisposition to cancer. Preface.
Hematology/oncology clinics of North America 2010;24(5):xi-xii.
2010: Zsofia Kinga Stadler; Peter Thom; Mark Robson; Jeffrey N Weitzel; Noah D Kauff; Karen E Hurley; Vincent Devlin; Bert Gold; Robert J. Klein; Kenneth Offit
Genome-wide association studies of cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(27):4255-67.
2010: Zsofia Kinga Stadler; Emmanuel Saloustros; Nichole A L Hansen; Alice E Schluger; Noah D Kauff; Kenneth Offit; Mark Robson
Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families.
Breast cancer research and treatment 2010;123(2):581-5.
2010: Zsofia Kinga Stadler; David J Gallagher; Peter Thom; Kenneth Offit
Genome-wide association studies of cancer: principles and potential utility.
Oncology (Williston Park, N.Y.) 2010;24(7):629-37.
2010: David J Gallagher; Joseph Vijai; Angel M Cronin; Jasmine Bhatia; Andrew J Vickers; Mia M. Gaudet; Samson W Fine; Victor E Reuter; Howard I Scher; Christer Halldén; Ana Dutra-Clarke; Robert J. Klein; Peter T Scardino; James A Eastham; Hans Lilja; Tomas Kirchhoff; Kenneth Offit
Susceptibility loci associated with prostate cancer progression and mortality.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(10):2819-32.
2010: Mary B Daly; Jennifer E Axilbund; Saundra Buys; Beth Crawford; Carolyn D Farrell; Susan Friedman; Judy E Garber; Salil Goorha; Stephen B Gruber; Heather Hampel; Virginia Kaklamani; Wendy Kohlmann; Allison Kurian; Jennifer Litton; P Kelly Marcom; Robert Nussbaum; Kenneth Offit; Tuya Pal; Boris Pasche; Robert Pilarski; Gwen Reiser; Kristen Mahoney Shannon; Jeffrey R Smith; Elizabeth Swisher; Jeffrey N Weitzel
Genetic/familial high-risk assessment: breast and ovarian.
Journal of the National Comprehensive Cancer Network : JNCCN 2010;8(5):562-94.
2010: Robert J. Klein; Christer Halldén; Angel M Cronin; Alexander Ploner; Fredrik Wiklund; Anders S Bjartell; Pär Stattin; Jianfeng Xu; Peter T Scardino; Kenneth Offit; Andrew J Vickers; Henrik Grönberg; Hans Lilja
Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer.
Cancer prevention research (Philadelphia, Pa.) 2010;3(5):611-9.
2010: David J Gallagher; Mia M. Gaudet; Prodipto Pal; Tomas Kirchhoff; Lisa Balistreri; Kinjal Vora; Jasmine Bhatia; Zsofia Kinga Stadler; Samson W Fine; Victor E Reuter; Michael J Zelefsky; Michael J Morris; Howard I Scher; Robert J. Klein; Larry Norton; James A Eastham; Peter T Scardino; Mark Robson; Kenneth Offit
Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(7):2115-21.
2010: Mark Robson; Courtney D Storm; Jeffrey Weitzel; Dana S Wollins; Kenneth Offit
American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(5):893-901.
2010: Kenneth Offit; Peter Thom
Ethicolegal aspects of cancer genetics.
Cancer treatment and research 2010;155():1-14.
2010: Bhavana Pothuri; Mario Leitao Jr; Douglas A Levine; Agnes Viale; Adam B Olshen; Crispinita D Arroyo; Faina Bogomolniy; Narciso Olvera; Oscar Lin; Robert A Soslow; Mark Robson; Kenneth Offit; Richard R Barakat; Jeff Boyd
Genetic analysis of the early natural history of epithelial ovarian carcinoma.
PloS one 2010;5(4):e10358.
2010: Susan M Domchek; Mia M. Gaudet; Jill Stopfer; M H Fleischaut; J Powers; Noah D Kauff; Kenneth Offit; K L Nathanson; Mark Robson
Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2.
Breast cancer research and treatment 2010;119(2):409-14.
2009: A Osorio; R L Milne; G Pita; P Peterlongo; T Heikkinen; J Simard; G Chenevix-Trench; A B Spurdle; J Beesley; X Chen; S Healey; S L Neuhausen; Y C Ding; F J Couch; X Wang; N Lindor; S Manoukian; M Barile; A Viel; L Tizzoni; C I Szabo; L Foretova; M Zikan; K Claes; M H Greene; P Mai; G Rennert; F Lejbkowicz; O Barnett-Griness; I L Andrulis; H Ozcelik; N Weerasooriya; A-M Gerdes; M Thomassen; D G Cruger; M A Caligo; Eitan Friedman; B Kaufman; Y Laitman; S Cohen; T Kontorovich; R Gershoni-Baruch; E Dagan; H Jernström; M S Askmalm; B Arver; B Malmer; S M Domchek; K L Nathanson; J Brunet; T Ramón Y Cajal; D Yannoukakos; U Hamann; F B L Hogervorst; S Verhoef; E B Gómez García; Juul Wijnen; A van den Ouweland; D F Easton; S Peock; M Cook; C T Oliver; D Frost; C Luccarini; D G Evans; Fiona Lalloo; R Eeles; G Pichert; J Cook; S Hodgson; P J Morrison; F Douglas; A K Godwin; O M Sinilnikova; L Barjhoux; D Stoppa-Lyonnet; V Moncoutier; S Giraud; C Cassini; L Olivier-Faivre; F Révillion; J-P Peyrat; D Muller; J-P Fricker; H T Lynch; E M John; S Buys; M Daly; J L Hopper; M B Terry; A Miron; Y Yassin; D Goldgar; C F Singer; D Gschwantler-Kaulich; G Pfeiler; A-C Spiess; Thomas V O Hansen; O T Johannsson; Tomas Kirchhoff; Kenneth Offit; K Kosarin; M Piedmonte; Gustavo Rodriguez; K Wakeley; J F Boggess; J Basil; P E Schwartz; S V Blank; A E Toland; M Montagna; C Casella; E N Imyanitov; A Allavena; R K Schmutzler; B Versmold; C Engel; A Meindl; N Ditsch; N Arnold; D Niederacher; H Deissler; B Fiebig; R Varon-Mateeva; D Schaefer; U G Froster; T Caldes; M de la Hoya; L McGuffog; A C Antoniou; H Nevanlinna; P Radice; J Benítez
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).
British journal of cancer 2009;101(12):2048-54.
2009: Antonis C Antoniou; Olga M Sinilnikova; Lesley McGuffog; Sue Healey; Heli Nevanlinna; Tuomas Heikkinen; Jacques Simard; Amanda B Spurdle; Jonathan Beesley; Xiaoqing Chen; Susan L Neuhausen; Yuan C Ding; Fergus J Couch; Xianshu Wang; Zachary Fredericksen; Paolo Peterlongo; Bernard Peissel; Bernardo Bonanni; Alessandra Viel; Loris Bernard; Paolo Radice; Csilla I Szabo; Lenka Foretova; Michal Zikan; Kathleen Claes; Mark H Greene; Phuong L Mai; Gad Rennert; Flavio Lejbkowicz; Irene L Andrulis; Hilmi Ozcelik; Gord Glendon; Anne-Marie Gerdes; Mads Thomassen; Lone Sunde; Maria A Caligo; Yael Laitman; Tair Kontorovich; Shimrit Cohen; Bella Kaufman; Efrat Dagan; Ruth Gershoni Baruch; Eitan Friedman; Katja Harbst; Gisela Barbany-Bustinza; Johanna Rantala; Hans Ehrencrona; Per Karlsson; Susan M Domchek; Katherine L Nathanson; Ana Osorio; Ignacio Blanco; Adriana Lasa; Javier Benítez; Ute Hamann; Frans B L Hogervorst; Matti A Rookus; J Margriet Collee; Peter Devilee; Marjolijn J Ligtenberg; Rob B van der Luijt; Cora M Aalfs; Quinten Waisfisz; Juul Wijnen; Cornelis E P van Roozendaal; Susan Peock; Margaret Cook; Debra Frost; Clare Oliver; Radka Platte; D Gareth Evans; Fiona Lalloo; Rosalind Eeles; Louise Izatt; Rosemarie Davidson; Carol Chu; Diana Eccles; Trevor Cole; Shirley Hodgson; Andrew K Godwin; Dominique Stoppa-Lyonnet; Bruno Buecher; Mélanie Léoné; Brigitte Bressac-de Paillerets; Audrey Remenieras; Olivier Caron; Gilbert M Lenoir; Nicolas Sevenet; Michel Longy; Sandra Fert Ferrer; Fabienne Prieur; David Goldgar; Alexander Miron; Esther M John; Saundra S Buys; Mary B Daly; John L Hopper; Mary Beth Terry; Yosuf Yassin; Christian Singer; Daphne Gschwantler-Kaulich; Christine Staudigl; Thomas v O Hansen; Rosa Bjork Barkardottir; Tomas Kirchhoff; Prodipto Pal; Kristi Kosarin; Kenneth Offit; Marion Piedmonte; Gustavo Rodriguez; Katie Wakeley; John F Boggess; Jack Basil; Peter E Schwartz; Stephanie V Blank; Amanda E Toland; Marco Montagna; Cinzia Casella; Evgeny N Imyanitov; Anna Allavena; Rita K Schmutzler; Beatrix Versmold; Christoph Engel; Alfons Meindl; Nina Ditsch; Norbert Arnold; Dieter Niederacher; Helmut Deissler; Britta Fiebig; Christian Suttner; Ines Schönbuchner; Dorothea Gadzicki; Trinidad Caldes; Miguel de la Hoya; Karen A Pooley; Douglas F Easton; Georgia Chenevix-Trench
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.
Human molecular genetics 2009;18(22):4442-56.
2009: Lili Li; Kajal Biswas; Laura Anne Habib; Sergey G Kuznetsov; Nancy Hamel; Tomas Kirchhoff; Nora Wong; Susan Armel; George Chong; Steven A Narod; Kathleen Claes; Kenneth Offit; Mark Robson; Stacey Stauffer; Shyam K Sharan; William D Foulkes
Functional redundancy of exon 12 of BRCA2 revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variant.
Human mutation 2009;30(11):1543-50.
2009: Jinru Shia; Laura H Tang; Efsevia Vakiani; Jose G Guillem; Zsofia Kinga Stadler; Robert A Soslow; Nora Katabi; Martin R Weiser; Philip B Paty; Larissa K Temple; Garrett M Nash; Douglas Wong; Kenneth Offit; David S Klimstra
Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel.
The American journal of surgical pathology 2009;33(11):1639-45.
2009: Stephen J Salipante; Matthew E Mealiffe; Jeremy Wechsler; Maxwell M Krem; Yajuan Liu; Shinae Namkoong; Govind Bhagat; Tomas Kirchhoff; Kenneth Offit; Henry Lynch; Peter H Wiernik; Mikhail Roshal; Mary Lou McMaster; Margaret Tucker; Jonathan R Fromm; Lynn R Goldin; Marshall S Horwitz
Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(35):14920-5.
2009: Tomas Kirchhoff; Zhang-qun Chen; Bert Gold; Prodipto Pal; Mia M. Gaudet; Kristi Kosarin; Douglas A Levine; Peter Gregersen; Sara Spencer; Megan Harlan; Mark Robson; Robert J. Klein; Clifford Hudis; Larry Norton; Michael Dean; Kenneth Offit
The 6q22.33 locus and breast cancer susceptibility.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(9):2468-75.
2009: Muin J Khoury; Colleen M McBride; Sheri D Schully; John Ioannidis; William G. Feero; A Cecile J W Janssens; Marta Gwinn; Denise Simons-Morton; Jay M Bernhardt; Michele Cargill; STEPHEN CHANOCK; George M Church; Ralph J Coates; Francis S Collins; Robert T Croyle; Barry R Davis; Gregory J Downing; Amy Duross; Susan Friedman; Mitchell H Gail; Geoffrey S Ginsburg; Robert C Green; Mark H Greene; Philip Greenland; Jeffrey R Gulcher; Andro Hsu; Kathy Hudson; Sharon L R Kardia; Paul L Kimmel; Michael Lauer; Amy M Miller; Kenneth Offit; David F Ransohoff; J Scott Roberts; Rebekah S Rasooly; Kari Stefansson; Sharon F Terry; Steven M Teutsch; Angela M Trepanier; Kay L Wanke; John S Witte; Jianfeng Xu
The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop.
Genetics in medicine : official journal of the American College of Medical Genetics 2009;11(8):559-67.
2009: Kenneth Offit
Breast cancer single-nucleotide polymorphisms: statistical significance and clinical utility.
Journal of the National Cancer Institute 2009;101(14):973-5.
2009: Gurinder Singh Atwal; Tomas Kirchhoff; Elisabeth E Bond; Marco Montagna; Marco Monagna; Chiara Menin; Roberta Bertorelle; Maria Chiara Scaini; Frank Bartel; Anja Böhnke; Christina Pempe; Elise Gradhand; Steffen Hauptmann; Kenneth Offit; Arnold J Levine; Gareth Bond
Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogene.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(25):10236-41.
2009: Liying Zhang; Tomas Kirchhoff; Cindy J Yee; Kenneth Offit
A rapid and reliable test for BRCA1 and BRCA2 founder mutation analysis in paraffin tissue using pyrosequencing.
The Journal of molecular diagnostics : JMD 2009;11(3):176-81.
2009: Liying Zhang; Ruben Bacares; Sherry Boyar; Clifford Hudis; Khedoudja Nafa; Kenneth Offit
cDNA analysis demonstrates that the BRCA2 intronic variant IVS4-12del5 is a deleterious mutation.
Mutation research 2009;663(1-2):84-9.
2009: Outi Kilpivaara; Semanti Mukherjee; Alison M Schram; Martha Wadleigh; Ann Mullally; Benjamin L Ebert; Adam Bass; Sachie Marubayashi; Adriana Heguy; Guillermo Garcia-Manero; Andrew Lamb; Kenneth Offit; Richard M Stone; D Gary Gilliland; Robert J. Klein; Ross Levine
A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms.
Nature genetics 2009;41(4):455-9.
2009: Cristina R Ferrone; Douglas A Levine; Laura H Tang; Peter J Allen; William R Jarnagin; Murray F Brennan; Kenneth Offit; Mark Robson
BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(3):433-8.
2008: Marc D Tischkowitz; Ahmet Yilmaz; Long Q Chen; Danielle M Karyadi; David Novak; Tomas Kirchhoff; Nancy Hamel; Sean V Tavtigian; Suzanne Kolb; Tarek A Bismar; Raquel Aloyz; Peter S Nelson; Lee Hood; Steven A Narod; Kirsten A White; Elaine A Ostrander; William B Isaacs; Kenneth Offit; Kathleen Cooney; Janet L Stanford; William D Foulkes
Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancer.
Cancer letters 2008;270(1):173-80.
2008: Virginia G Kaklamani; Kari B Wisinski; Maureen Sadim; Cassandra Gulden; Albert Do; Kenneth Offit; John A Baron; Habibul Ahsan; Christos Mantzoros; Boris Pasche
Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk.
JAMA : the journal of the American Medical Association 2008;300(13):1523-31.
2008: Courtney Storm; Rinki Agarwal; Kenneth Offit
Ethical and legal implications of cancer genetic testing: do physicians have a duty to warn patients' relatives about possible genetic risks?
Journal of oncology practice / American Society of Clinical Oncology 2008;4(5):229-30.
2008: Jenifer L Marks; Ben Golas; Tomas Kirchoff; Vincent A Miller; Gregory J Riely; Kenneth Offit; William Pao
EGFR mutant lung adenocarcinomas in patients with germline BRCA mutations.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(7):805.
2008: Sajid A Khan; Kamran Idrees; Ann Forslund; Zhaoshi Zeng; Shoshana Rosenberg; Hanna Pincas; Francis Barany; Kenneth Offit; Michael P LaQuaglia; Philip B Paty
Genetic variants in germline TP53 and MDM2 SNP309 are not associated with early onset colorectal cancer.
Journal of surgical oncology 2008;97(7):621-5.
2008: Virginia G Kaklamani; Maureen Sadim; Alex Hsi; Kenneth Offit; Carole Oddoux; Harry Ostrer; Habibul Ahsan; Boris Pasche; Christos Mantzoros
Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk.
Cancer research 2008;68(9):3178-84.
2008: Manny Bacolod; Gunter S Schemmann; Shuang Wang; Richard Shattock; Sarah F Giardina; Zhaoshi Zeng; Jinru Shia; Robert F Stengel; Norman Gerry; Josephine Hoh; Tomas Kirchhoff; Bert Gold; Michael F Christman; Kenneth Offit; William L Gerald; Daniel A Notterman; Jurg Ott; Philip B Paty; Francis Barany
The signatures of autozygosity among patients with colorectal cancer.
Cancer research 2008;68(8):2610-21.
2008: Kenneth Offit
Genomic profiles for disease risk: predictive or premature?
JAMA : the journal of the American Medical Association 2008;299(11):1353-5.
2008: Bert Gold; Tomas Kirchhoff; Stefan Stefanov; James Lautenberger; Agnes Viale; Judy E Garber; Eitan Friedman; steven narod; Adam B Olshen; Peter Gregersen; Kristi Kosarin; Adam Olsh; Julie Bergeron; Nathan Ellis; Robert J. Klein; andrew clark; Larry Norton; Michael Dean; Jeff Boyd; Kenneth Offit
Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(11):4340-5.
2008: Noah D Kauff; Susan M Domchek; Tara M Friebel; Mark Robson; Johanna Lee; Judy E Garber; Claudine Isaacs; D Gareth Evans; Henry Lynch; Rosalind A Eeles; Susan L Neuhausen; Mary B Daly; Ellen Matloff; Joanne L Blum; Paul Sabbatini; Richard R Barakat; Clifford Hudis; Larry Norton; Kenneth Offit; Timothy R Rebbeck
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(8):1331-7.
2008: Kenneth Offit; Judy E Garber
Time to check CHEK2 in families with breast cancer?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(4):519-20.
2008: Adam B Olshen; Bert Gold; Kirk E Lohmueller; Jeffery Struewing; Jaya M Satagopan; Stefan A Stefanov; Eleazar Eskin; Tomas Kirchhoff; James A Lautenberger; Robert J. Klein; Eitan Friedman; Larry Norton; Nathan Ellis; Agnes Viale; Catherine S Lee; Patrick I Borgen; andrew clark; Kenneth Offit; Jeff Boyd
Analysis of genetic variation in Ashkenazi Jews by high density SNP genotyping.
BMC genetics 2008;9():14.
2007: Antonis C Antoniou; Olga M Sinilnikova; Jacques Simard; Mélanie Léoné; Martine Dumont; Susan L Neuhausen; Jeffery P Struewing; Dominique Stoppa-Lyonnet; Laure Barjhoux; David J Hughes; Isabelle Coupier; Muriel Belotti; Christine Lasset; Valérie Bonadona; Yves-Jean Bignon; Timothy R Rebbeck; Theresa Wagner; Henry T Lynch; Susan M Domchek; Katherine L Nathanson; Judy E Garber; Jeffrey N Weitzel; steven narod; Gail Tomlinson; Olufunmilayo I Olopade; Andrew Godwin; Claudine Isaacs; Anna Jakubowska; Jan Lubinski; Jacek Gronwald; Bohdan Górski; Tomasz Byrski; Tomasz Huzarski; Susan Peock; Margaret Cook; Caroline Baynes; Alexandra Murray; Mark Rogers; Peter A Daly; Huw Dorkins; Rita K Schmutzler; Beatrix Versmold; Christoph Engel; Alfons Meindl; Norbert Arnold; Dieter Niederacher; Helmut Deissler; Amanda B Spurdle; Xiaoqing Chen; Nicola Waddell; Nicole Cloonan; Tomas Kirchhoff; Kenneth Offit; Eitan Friedman; Bella Kaufmann; Yael Laitman; Gilli Galore; Gad Rennert; Flavio Lejbkowicz; Leonid Raskin; Irene L Andrulis; Eduard Ilyushik; Hilmi Ozcelik; Peter Devilee; Maaike P G Vreeswijk; Mark H Greene; Sheila A Prindiville; Ana Osorio; Javier Benitez; Michal Zikan; Csilla I Szabo; Outi Kilpivaara; Heli Nevanlinna; Ute Hamann; Francine Durocher; Adalgeir Arason; Fergus J. Couch; Douglas F Easton; Georgia Chenevix-Trench
RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.
American journal of human genetics 2007;81(6):1186-200.
2007: Miguel Angel Pujana; Jing-Dong J Han; Lea M Starita; Kristen N Stevens; Muneesh Tewari; Jin Sook Ahn; Gad Rennert; Víctor Moreno; Tomas Kirchhoff; Bert Gold; Volker Assmann; Wael ElShamy; Jean-François Rual; Douglas A Levine; Laura S Rozek; Rebecca Gelman; Kristin C Gunsalus; Roger A. Greenberg; Bijan Sobhian; Nicolas Bertin; Kavitha Venkatesan; Nono Ayivi-Guedehoussou; Xavier Sole; Pilar Hernández; Conxi Lázaro; Katherine L Nathanson; Barbara L Weber; Michael E Cusick; David E Hill; Kenneth Offit; David M Livingston; Stephen B Gruber; Jeffrey D Parvin; Marc Vidal
Network modeling links breast cancer susceptibility and centrosome dysfunction.
Nature genetics 2007;39(11):1338-49.
2007: Kenneth Offit; Peter Thom
Ethical and legal aspects of cancer genetic testing.
Seminars in oncology 2007;34(5):435-43.
2007: Joanne Kotsopoulos; Jan Lubinski; Henry T Lynch; Jan Klijn; Parviz Ghadirian; Susan L Neuhausen; Charmaine Kim-Sing; William D Foulkes; Pal Moller; Claudine Isaacs; Susan Domchek; Susan Randall; Kenneth Offit; Nadine Tung; Peter Ainsworth; Ruth Gershoni-Baruch; Andrea Eisen; Mary Daly; Beth Y Karlan; Howard M Saal; Fergus J. Couch; Barbara Pasini; Teresa Wagner; Eitan Friedman; Gad Rennert; Charis Eng; Jeffrey N Weitzel; Ping Sun; steven narod; Judy E Garber; M Osborne; D Fishman; J McLennan; W McKinnon; Sofia D Merajver; H Olsson; D Provencher; B Pasche; G Evans; W S Meschino; E Lemire; A Chudley; D Rayson; C Bellati
Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Breast cancer research and treatment 2007;105(2):221-8.
2007: Tari A King; Weiwei Li; Edi Brogi; Cindy J Yee; Mary L Gemignani; Narciso Olvera; Douglas A Levine; Larry Norton; Mark Robson; Kenneth Offit; Patrick I Borgen; Jeff Boyd
Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis.
Annals of surgical oncology 2007;14(9):2510-8.
2007: Karen Lisa Smith; Muriel Adank; Noah D Kauff; Kelly J Lafaro; Jeff Boyd; Johanna B Lee; Clifford Hudis; Kenneth Offit; Mark Robson
BRCA mutations in women with ductal carcinoma in situ.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(14):4306-10.
2007: Mark Robson; Kenneth Offit
Clinical practice. Management of an inherited predisposition to breast cancer.
The New England journal of medicine 2007;357(2):154-62.
2007: Fergus J. Couch; Olga Sinilnikova; Robert A Vierkant; V Shane Pankratz; Zachary S Fredericksen; Dominique Stoppa-Lyonnet; Isabelle Coupier; David Hughes; Agnès Hardouin; Pascaline Berthet; Susan Peock; Margaret Cook; Caroline Baynes; Shirley Hodgson; Patrick J Morrison; Mary E Porteous; Anna Jakubowska; Jan Lubinski; Jacek Gronwald; Amanda B Spurdle; Rita Schmutzler; Beatrix Versmold; Christoph Engel; Alfons Meindl; Christian Sutter; Jurgen Horst; Dieter Schaefer; Kenneth Offit; Tomas Kirchhoff; Irene L Andrulis; Eduard Ilyushik; Gordon Glendon; Peter Devilee; Maaike P G Vreeswijk; Hans Vasen; Ake Borg; Katja Backenhorn; Jeffery P Struewing; Mark H Greene; Susan L Neuhausen; Timothy R Rebbeck; Katherine Nathanson; Susan Domchek; Theresa Wagner; Judy E Garber; Csilla Szabo; Michal Zikan; Lenka Foretova; Janet E Olson; Thomas A Sellers; Noralane Lindor; Heli Nevanlinna; Johanna Tommiska; Kristiina Aittomaki; Ute Hamann; M Rashid; Diana Torres; Jacques Simard; Francine Durocher; Frederic Guenard; Henry T Lynch; Claudine Isaacs; Jeffrey N Weitzel; Olufunmilayo I Olopade; steven narod; Mary B Daly; Andrew K Godwin; Gail Tomlinson; Douglas F Easton; Georgia Chenevix-Trench; Antonis C Antoniou
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(7):1416-21.
2007: Noah D Kauff; Kenneth Offit
Modeling genetic risk of breast cancer.
JAMA : the journal of the American Medical Association 2007;297(23):2637-9.
2007: Marta Sanchez-Carbayo; Nicholas D Socci; Thomas Kirchoff; Nadina Erill; Kenneth Offit; Bernard H Bochner; Carlos Cordon-Cardo
A polymorphism in HDM2 (SNP309) associates with early onset in superficial tumors, TP53 mutations, and poor outcome in invasive bladder cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(11):3215-20.
2007: Jose G Guillem; Emily Glogowski; Harvey G Moore; Khedoudja Nafa; Arnold J Markowitz; Jinru Shia; Kenneth Offit; Nathan Ellis
Single-amplicon MSH2 A636P mutation testing in Ashkenazi Jewish patients with colorectal cancer: role in presurgical management.
Annals of surgery 2007;245(4):560-5.
2007: Lutécia H Mateus Pereira; Marbin A Pineda; William H Rowe; Libia R Fonseca; Mark H Greene; Kenneth Offit; Nathan Ellis; Jinghui Zhang; ANDREW COLLINS; Jeffery Struewing
The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studies.
BMC genetics 2007;8():68.
2007: John R McLaughlin; Harvey A Risch; Jan Lubinski; Pal Moller; Parviz Ghadirian; Henry T Lynch; Beth Y Karlan; David Fishman; Barry Rosen; Susan L Neuhausen; Kenneth Offit; Noah D Kauff; Susan M Domchek; Nadine Tung; Eitan Friedman; William D Foulkes; Ping Sun; Steven A Narod
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.
The lancet oncology 2007;8(1):26-34.
2006: Kenneth Offit; Michal Sagi; Karen E Hurley
Preimplantation genetic diagnosis for cancer syndromes: a new challenge for preventive medicine.
JAMA : the journal of the American Medical Association 2006;296(22):2727-30.
2006: Kenneth Offit
BRCA mutation frequency and penetrance: new data, old debate.
Journal of the National Cancer Institute 2006;98(23):1675-7.
2006: Deborah Goldfrank; Shaokun Chuai; Jonine L Bernstein; Teresa Ramon Y Cajal; Johanna B Lee; M Carmen Alonso; Orland Diez; Montserrat Baiget; Noah D Kauff; Kenneth Offit; Mark Robson
Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(11):2311-3.
2006: Paolo Peterlongo; Nandita Mitra; Ana Sanchez de Abajo; Miguel de la Hoya; Chiara Bassi; Lucio Bertario; Paolo Radice; Emily Glogowski; Khedoudja Nafa; Trinidad Caldes; Kenneth Offit; Nathan Ellis
Increased frequency of disease-causing MYH mutations in colon cancer families.
Carcinogenesis 2006;27(11):2243-9.
2006: Kenneth Offit; Kelly Kohut; Bartholt Clagett; Eve A Wadsworth; Kelly J Lafaro; Shelly Cummings; Melody White; Michal Sagi; Donna Bernstein; Jessica G Davis
Cancer genetic testing and assisted reproduction.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(29):4775-82.
2006: Jose G Guillem; William C Wood; Jeffrey F Moley; Andrew Berchuck; Beth Y Karlan; David G Mutch; Robert F Gagel; Jeffrey N Weitzel; Monica Morrow; Barbara L Weber; Francis M Giardiello; Miguel A Rodriguez-Bigas; James Church; Stephen B Gruber; Kenneth Offit
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(28):4642-60.
2006: Jose G Guillem; William C Wood; Jeffrey F Moley; Andrew Berchuck; Beth Y Karlan; David G Mutch; Robert F Gagel; Jeffrey N Weitzel; Monica Morrow; Barbara L Weber; Francis M Giardiello; Miguel A Rodriguez-Bigas; James Church; Stephen B Gruber; Kenneth Offit
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes.
Annals of surgical oncology 2006;13(10):1296-321.
2006: Sining Chen; Wenyi Wang; Shing Lee; Khedoudja Nafa; Johanna Lee; Katharine E Romans; Patrice Watson; Stephen B Gruber; David M Euhus; Kenneth W Kinzler; Jeremy Jass; Steven Gallinger; Noralane M Lindor; Graham Casey; Nathan Ellis; Francis M Giardiello; Kenneth Offit; Giovanni Parmigiani
Prediction of germline mutations and cancer risk in the Lynch syndrome.
JAMA : the journal of the American Medical Association 2006;296(12):1479-87.
2006: Patricia Anne Ganz; Lorna Kwan; Mark R Somerfield; David Alberts; Judy E Garber; Kenneth Offit; Scott M Lippman
The role of prevention in oncology practice: results from a 2004 survey of American Society of Clinical Oncology members.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(18):2948-57.
2006: Gareth Bond; Kim M Hirshfield; Tomas Kirchhoff; Gabriella Alexe; Elisabeth E Bond; Harlan Robins; Frank Bartel; Helge Taubert; Peter Wuerl; William N Hait; Deborah Toppmeyer; Kenneth Offit; Arnold J Levine
MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner.
Cancer research 2006;66(10):5104-10.
2006: Jacek Gronwald; Nadine Tung; William D Foulkes; Kenneth Offit; Ruth Gershoni; Mary Daly; Charmaine Kim-Sing; Håkan Olsson; Peter Ainsworth; Andrea Eisen; Howard M Saal; Eitan Friedman; Olufunmilayo I Olopade; Michael Osborne; Jeffrey N Weitzel; Henry T Lynch; Parviz Ghadirian; Jan Lubinski; Ping Sun; Steven A Narod
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update.
International journal of cancer. Journal international du cancer 2006;118(9):2281-4.
2006: Mary B Daly; Jennifer E Axilbund; Eileen Bryant; Saundra S Buys; Charis Eng; Susan Friedman; Laura J Esserman; Carolyn D Farrell; James M Ford; Judy E Garber; Joanne M Jeter; Wendy Kohlmann; Patrick M Lynch; Paul Kelly Marcom; Lisle M Nabell; Kenneth Offit; Raymond U Osarogiagbon; Boris Pasche; Gwen Reiser; Rebecca Sutphen; Jeffrey N Weitzel
Genetic/familial high-risk assessment: breast and ovarian.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(2):156-76.
2006: Kenneth Offit; Noah D Kauff
Reducing the risk of gynecologic cancer in the Lynch syndrome.
The New England journal of medicine 2006;354(3):293-5.
2006: Lois B Travis; Charles S Rabkin; Linda Morris Brown; James M Allan; BLANCHE ALTER; Christine B Ambrosone; Colin B Begg; Neil Caporaso; STEPHEN CHANOCK; Angela DeMichele; William Douglas Figg; Mary K Gospodarowicz; Eric J Hall; Michie Hisada; Peter D Inskip; Ruth A Kleinerman; John B Little; David Malkin; Andrea K Ng; Kenneth Offit; Ching-Hon Pui; Leslie L Robison; Nathaniel Rothman; Peter G Shields; Louise Strong; Toshiyasu Taniguchi; Margaret A Tucker; Mark H Greene
Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations.
Journal of the National Cancer Institute 2006;98(1):15-25.
2006: M A Adank; Edi Brogi; Faina Bogomolniy; Eve A Wadsworth; Kelly J Lafaro; Cindy J Yee; Tomas Kirchhoff; E J Meijers-Heijboer; Noah D Kauff; Jeff Boyd; Kenneth Offit
Accuracy of BRCA1 and BRCA2 founder mutation analysis in formalin-fixed and paraffin-embedded (FFPE) tissue.
Familial cancer 2006;5(4):337-42.
2006: Eitan Friedman; Joanne Kotsopoulos; Jan Lubinski; Henry T Lynch; Parviz Ghadirian; Susan L Neuhausen; Claudine Isaacs; Barbara Weber; William D Foulkes; Pal Moller; Barry Rosen; Charmaine Kim-Sing; Ruth Gershoni-Baruch; Peter Ainsworth; Mary Daly; Nadine Tung; Andrea Eisen; Olufunmilayo I Olopade; Beth Y Karlan; Howard M Saal; Judy E Garber; Gad Rennert; Dawna Gilchrist; Charis Eng; Kenneth Offit; Michael Osborne; Ping Sun; Steven A Narod
Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers.
Breast cancer research : BCR 2006;8(2):R15.
2006: Nathan Ellis; Tomas Kirchhoff; Nandita Mitra; Tian-Zhang Ye; Shaokun Chuai; Helen Huang; Khedoudja Nafa; Larry Norton; Susan L Neuhausen; Derek Gordon; Jeffery Struewing; Steven A Narod; Kenneth Offit
Localization of breast cancer susceptibility loci by genome-wide SNP linkage disequilibrium mapping.
Genetic epidemiology 2006;30(1):48-61.
2005: Carey A Cullinane; Jan Lubinski; Susan L Neuhausen; Parviz Ghadirian; Henry T Lynch; Claudine Isaacs; Barbara Weber; Pal Moller; Kenneth Offit; Charmaine Kim-Sing; Eitan Friedman; Susan Randall; Barbara Pasini; Peter Ainsworth; Ruth Gershoni-Baruch; William D Foulkes; Jan Klijn; Nadine Tung; Gad Rennert; Olufunmilayo I Olopade; Fergus J. Couch; Teresa Wagner; Håkan Olsson; Ping Sun; Jeffrey N Weitzel; Steven A Narod
Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers.
International journal of cancer. Journal international du cancer 2005;117(6):988-91.
2005: Rob Finch; Harvey G Moore; Noralane M Lindor; Syed M Jalal; Arnold J Markowitz; Jhanwar Suresh; Kenneth Offit; Jose G Guillem
Familial adenomatous polyposis and mental retardation caused by a de novo chromosomal deletion at 5q15-q22: report of a case.
Diseases of the colon and rectum 2005;48(11):2148-52.
2005: Andrea Eisen; Jan Lubinski; Jan Klijn; Pal Moller; Henry T Lynch; Kenneth Offit; Barbara Weber; Tim Rebbeck; Susan L Neuhausen; Parviz Ghadirian; William D Foulkes; Ruth Gershoni-Baruch; Eitan Friedman; Gadi Rennert; Teresa Wagner; Claudine Isaacs; Charmaine Kim-Sing; Peter Ainsworth; Ping Sun; Steven A Narod
Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7491-6.
2005: Noah D Kauff; Nandita Mitra; Mark Robson; Karen E Hurley; Shaokun Chuai; Deborah Goldfrank; Eve A Wadsworth; Johanna Lee; Tessa Cigler; Patrick I Borgen; Larry Norton; Richard R Barakat; Kenneth Offit
Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
Journal of the National Cancer Institute 2005;97(18):1382-4.
2005: Noah D Kauff; Karen E Hurley; Martee Hensley; Mark Robson; Gali Lev; Deborah Goldfrank; Mercedes Castiel; Carol L Brown; Jamie S Ostroff; Lucy E Hann; Kenneth Offit; Richard R Barakat
Ovarian carcinoma screening in women at intermediate risk: impact on quality of life and need for invasive follow-up.
Cancer 2005;104(2):314-20.
2005: Paolo Peterlongo; Louise R Howe; Paolo Radice; Paola Sala; Young-Joon Hong; Seok-Il Hong; Nandita Mitra; Kenneth Offit; Nathan Ellis
Germline mutations of AXIN2 are not associated with nonsyndromic colorectal cancer.
Human mutation 2005;25(5):498-500.
2005: Virginia G Kaklamani; Lisa Baddi; Junjian Liu; Diana Rosman; Sharbani Phukan; Ciarán Bradley; Chris Hegarty; Bree McDaniel; Alfred Rademaker; Carole Oddoux; Harry Ostrer; Loren S Michel; Helen Huang; Yu Chen; Habibul Ahsan; Kenneth Offit; Boris Pasche
Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.
Cancer research 2005;65(8):3454-61.
2005: Paolo Peterlongo; Nandita Mitra; Shaokun Chuai; Tomas Kirchhoff; Crystal Palmer; Helen Huang; Khedoudja Nafa; Kenneth Offit; Nathan Ellis
Colorectal cancer risk in individuals with biallelic or monoallelic mutations of MYH.
International journal of cancer. Journal international du cancer 2005;114(3):505-7.
2005: Steven A Narod; Kenneth Offit
Prevention and management of hereditary breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(8):1656-63.
2005: Avraham Shaag; Tom Walsh; Paul Renbaum; Tomas Kirchhoff; Khedoudja Nafa; Stacey Shiovitz; Jessica B Mandell; Piri Welcsh; Ming K Lee; Nathan Ellis; Kenneth Offit; Ephrat Levy-Lahad; Mary-Claire King
Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish population.
Human molecular genetics 2005;14(4):555-63.
2005: Judy E Garber; Kenneth Offit
Hereditary cancer predisposition syndromes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(2):276-92.
2005: Rina Siddiqui; Kenan Onel; Flavia Facio; Khedoudja Nafa; Louis Robles Diaz; Noah D Kauff; Helen Huang; Mark Robson; Nathan Ellis; Kenneth Offit
The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li-Fraumeni-like kindreds.
Familial cancer 2005;4(2):177-81.
2005: Jinru Shia; David S Klimstra; Khedoudja Nafa; Kenneth Offit; Jose G Guillem; Arnold J Markowitz; William L Gerald; Nathan Ellis
Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms.
The American journal of surgical pathology 2005;29(1):96-104.
2005: Destin Black; Faina Bogomolniy; Mark Robson; Kenneth Offit; Richard R Barakat; Jeff Boyd
Evaluation of germline PTEN mutations in endometrial cancer patients.
Gynecologic oncology 2005;96(1):21-4.
2005: Mark Robson; Tiffany Svahn; Beryl Mc Cormick; Patrick I Borgen; Clifford Hudis; Larry Norton; Kenneth Offit
Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series.
Cancer 2005;103(1):44-51.
2004: Bert Gold; Francis Kalush; Julie Bergeron; Kevin Scott; Nandita Mitra; Kelly Wilson; Nathan Ellis; Helen Huang; Michael Chen; Ross Lippert; Bjarni V Halldorsson; Beth Woodworth; Thomas White; andrew clark; Fritz F Parl; Samuel Broder; Michael Dean; Kenneth Offit
Estrogen receptor genotypes and haplotypes associated with breast cancer risk.
Cancer research 2004;64(24):8891-900.
2004: Kenneth Offit
MSH6 mutations in hereditary nonpolyposis colon cancer: another slice of the pie.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(22):4449-51.
2004: Nandita Mitra; Tian-Zhang Ye; Alex Smith; Shaokun Chuai; Tomas Kirchhoff; Paolo Peterlongo; Khedoudja Nafa; Michael S Phillips; Kenneth Offit; Nathan Ellis
Localization of cancer susceptibility genes by genome-wide single-nucleotide polymorphism linkage-disequilibrium mapping.
Cancer research 2004;64(21):8116-25.
2004: Virginia G Kaklamani; Lisa Baddi; Diana Rosman; Junjian Liu; Nathan Ellis; Carole Oddoux; Harry Ostrer; Yu Chen; Habibul Ahsan; Kenneth Offit; Boris Pasche
No major association between TGFBR1*6A and prostate cancer.
BMC genetics 2004;5():28.
2004: Kenneth Offit; Elizabeth Groeger; Sam Turner; Eve A Wadsworth; Mary A Weiser
The "duty to warn" a patient's family members about hereditary disease risks.
JAMA : the journal of the American Medical Association 2004;292(12):1469-73.
2004: Mark Robson; Kenneth Offit
Breast MRI for women with hereditary cancer risk.
JAMA : the journal of the American Medical Association 2004;292(11):1368-70.
2004: Rina Siddiqui; Kenan Onel; Flavia Facio; Kenneth Offit
The genetics of familial lymphomas.
Current oncology reports 2004;6(5):380-7.
2004: Tari A King; Mary L Gemignani; Weiwei Li; Dilip D Giri; Katherine S Panageas; Faina Bogomolniy; Crispinita D Arroyo; Narciso Olvera; Mark Robson; Kenneth Offit; Patrick I Borgen; Jeff Boyd
Increased progesterone receptor expression in benign epithelium of BRCA1-related breast cancers.
Cancer research 2004;64(15):5051-3.
2004: Tomas Kirchhoff; Noah D Kauff; Nandita Mitra; Khedoudja Nafa; Helen Huang; Crystal Palmer; Tony Gulati; Eve A Wadsworth; S Machele Donat; Mark Robson; Nathan Ellis; Kenneth Offit
BRCA mutations and risk of prostate cancer in Ashkenazi Jews.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(9):2918-21.
2004: Mark Robson; Emily Glogowski; Gunhild Sommer; Cristina R Antonescu; Khedoudja Nafa; ROBERT G MAKI; Nathan Ellis; Peter Besmer; Murray F Brennan; Kenneth Offit
Pleomorphic characteristics of a germ-line KIT mutation in a large kindred with gastrointestinal stromal tumors, hyperpigmentation, and dysphagia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(4):1250-4.
2004: Boris Pasche; Virginia G Kaklamani; Nanjiang Hou; Taya Young; Alfred Rademaker; Paolo Peterlongo; Nathan Ellis; Kenneth Offit; Trinidad Caldes; Michael Reiss; Tongzhang Zheng
TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(4):756-8.
2004: Heather Hampel; Kevin M Sweet; Judith A Westman; Kenneth Offit; Charis Eng
Referral for cancer genetics consultation: a review and compilation of risk assessment criteria.
Journal of medical genetics 2004;41(2):81-91.
2004: Tomas Kirchhoff; Jaya M Satagopan; Noah D Kauff; Helen Huang; Prema Kolachana; Crystal Palmer; Hannah Rapaport; Khedoudja Nafa; Nathan Ellis; Kenneth Offit
Frequency of BRCA1 and BRCA2 mutations in unselected Ashkenazi Jewish patients with colorectal cancer.
Journal of the National Cancer Institute 2004;96(1):68-70.
2004: Luis Robles-Díaz; Deborah Goldfrank; Noah D Kauff; Mark Robson; Kenneth Offit
Hereditary ovarian cancer in Ashkenazi Jews.
Familial cancer 2004;3(3-4):259-64.
2004: Jose G Guillem; Harvey G Moore; Crystal Palmer; Emily Glogowski; Rob Finch; Khedoudja Nafa; Arnold J Markowitz; Kenneth Offit; Nathan Ellis
A636P testing in Ashkenazi Jews.
Familial cancer 2004;3(3-4):223-7.
2004: Mark Robson; Pierre O Chappuis; Jaya M Satagopan; Nora Wong; Jeff Boyd; John R Goffin; Clifford Hudis; David Roberge; Larry Norton; Louis R Bégin; Kenneth Offit; William D Foulkes
A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment.
Breast cancer research : BCR 2004;6(1):R8-R17.
2003: Paolo Peterlongo; Khedoudja Nafa; Gabriel S Lerman; Emily Glogowski; Jinru Shia; Tian-Zhang Ye; Arnold J Markowitz; Jose G Guillem; Prema Kolachana; Jeffrey A Boyd; Kenneth Offit; Nathan Ellis
MSH6 germline mutations are rare in colorectal cancer families.
International journal of cancer. Journal international du cancer 2003;107(4):571-9.
2003: Douglas A Levine; Peter A Argenta; Cindy J Yee; David S Marshall; Narciso Olvera; Faina Bogomolniy; Jamal Rahaman; Mark Robson; Kenneth Offit; Richard R Barakat; Robert A Soslow; Jeff Boyd
Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(22):4222-7.
2003: Jinru Shia; Nathan Ellis; Philip B Paty; Garrett M Nash; Jing Qin; Kenneth Offit; Xin-Min Zhang; Arnold J Markowitz; Khedoudja Nafa; Jose G Guillem; Douglas Wong; William L Gerald; David S Klimstra
Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer.
The American journal of surgical pathology 2003;27(11):1407-17.
2003: Kenneth Offit; Orna Levran; Brian Mullaney; Katherine Mah; Khedoudja Nafa; Sat Dev Batish; Raffaella Diotti; Hildegard Schneider; Amie M Deffenbaugh; Thomas Scholl; Virginia K Proud; Mark Robson; Larry Norton; Nathan Ellis; Helmut Hanenberg; Arleen D Auerbach
Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia.
Journal of the National Cancer Institute 2003;95(20):1548-51.
2003: Virginia G Kaklamani; Nanjiang Hou; Yansong Bian; Jennifer Reich; Kenneth Offit; Loren S Michel; W S Rubinstein; Alfred Rademaker; Boris Pasche
TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(17):3236-43.
2003: Caroline Bäumler; Fei Duan; Kenan Onel; Beth Rapaport; Suresh C Jhanwar; Kenneth Offit; Keith B Elkon
Differential recruitment of caspase 8 to cFlip confers sensitivity or resistance to Fas-mediated apoptosis in a subset of familial lymphoma patients.
Leukemia research 2003;27(9):841-51.
2003: Mark Robson; Martee Hensley; Richard R Barakat; Carol L Brown; Dennis S Chi; Elizabeth A Poynor; Kenneth Offit
Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy.
Gynecologic oncology 2003;89(2):281-7.
2003: Noah D Kauff; Edi Brogi; Lauren Scheuer; Dorothy R Pathak; Patrick I Borgen; Clifford Hudis; Kenneth Offit; Mark Robson
Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations.
Cancer 2003;97(7):1601-8.
2003: Jose G Guillem; Beth Rapaport; Tomas Kirchhoff; Prema Kolachana; Khedoudja Nafa; Emily Glogowski; Rob Finch; Helen Huang; William D Foulkes; Arnold J Markowitz; Nathan Ellis; Kenneth Offit
A636P is associated with early-onset colon cancer in Ashkenazi Jews.
Journal of the American College of Surgeons 2003;196(2):222-5.
2003: Kenneth Offit; Heather Hanson Pierce; Tomas Kirchhoff; Prema Kolachana; Beth Rapaport; Peter Gregersen; Steven Johnson; Ofer Yossepowitch; Helen Huang; Jaya M Satagopan; Mark Robson; Lauren Scheuer; Khedoudja Nafa; Nathan Ellis
Frequency of CHEK2*1100delC in New York breast cancer cases and controls.
BMC medical genetics 2003;4():1.
2003: Ofer Yossepowitch; Narciso Olvera; Jaya M Satagopan; Helen Huang; Suresh C Jhanwar; Beth Rapaport; Jeff Boyd; Kenneth Offit
BRCA1 and BRCA2 germline mutations in lymphoma patients.
Leukemia & lymphoma 2003;44(1):127-31.
2002: steven narod; Marie-Pierre Dubé; Jan Klijn; Jan Lubinski; Henry T Lynch; Parviz Ghadirian; Diane Provencher; Ketil Heimdal; Pal Moller; Mark Robson; Kenneth Offit; Claudine Isaacs; Barbara Weber; Eitan Friedman; Ruth Gershoni-Baruch; Gad Rennert; Barbara Pasini; Theresa Wagner; Mary Daly; Judy E Garber; Susan L Neuhausen; Peter Ainsworth; Hakan Olsson; Gareth Evans; Michael Osborne; Fergus J. Couch; William D Foulkes; Ellen Warner; Charmaine Kim-Sing; Olufunmilayo Olopade; Nadine Tung; Howard M Saal; Jeffrey N Weitzel; Sofia D Merajver; Marion Gauthier-Villars; Helena Jernstrom; Ping Sun; Jean-Sebastien Brunet
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Journal of the National Cancer Institute 2002;94(23):1773-9.
2002: Haley Thompson; Heiddis B Valdimarsdottir; Chantal Duteau-Buck; Josephine S Guevarra; Dana H Bovbjerg; Cassandra Richmond-Avellaneda; David Amarel; Diana Godfrey; Karen Brown; Kenneth Offit
Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(12):1579-85.
2002: Kenneth Offit; Shlomit Gilad; Shoshana Paglin; Prema Kolachana; Laila Roisman; Khedoudja Nafa; Vincent Yeugelewitz; Maria Gonzales; Mark Robson; Deborah McDermott; Heather Hanson Pierce; Noah D Kauff; Paz Einat; Suresh C Jhanwar; Jaya M Satagopan; Carole Oddoux; Nathan Ellis; Rami Skaliter; Joachim Yahalom
Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(12):3813-9.
2002: Jaya M Satagopan; Jeff Boyd; Noah D Kauff; Mark Robson; Lauren Scheuer; Steven A Narod; Kenneth Offit
Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(12):3776-81.
2002: W D Foulkes; I Thiffault; Stephen B Gruber; M Horwitz; N Hamel; C Lee; Jinru Shia; Arnold J Markowitz; A Figer; Eitan Friedman; D Farber; C M T Greenwood; J D Bonner; K Nafa; T Walsh; V Marcus; L Tomsho; J Gebert; F A Macrae; C L Gaff; B Bressac-De Paillerets; P K Gregersen; Jeffrey N Weitzel; P H Gordon; E MacNamara; M-C King; H Hampel; ALBERT DE LA CHAPELLE; J Boyd; Kenneth Offit; G Rennert; G Chong; Nathan Ellis
The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.
American journal of human genetics 2002;71(6):1395-412.
2002: William B Archey; Kristen A McEachern; Mark Robson; Kenneth Offit; Susan A J Vaziri; Graham Casey; Ake Borg; Bradley A Arrick
Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers.
Oncogene 2002;21(46):7034-41.
2002: Mark Robson; Kenneth Offit
Considerations in genetic counseling for inherited breast cancer predisposition.
Seminars in radiation oncology 2002;12(4):362-70.
2002: Stephen B Gruber; Nathan Ellis; Karen K Scott; Ronit Almog; Prema Kolachana; Joseph D Bonner; Tomas Kirchhoff; Lynn P Tomsho; Khedoudja Nafa; Heather Hanson Pierce; Marcelo Low; Jaya M Satagopan; Hanna Rennert; Helen Huang; Joel K Greenson; Joanna Groden; Beth Rapaport; Jinru Shia; Stephen Johnson; Peter K Gregersen; Curtis C Harris; Jeff Boyd; Gad Rennert; Kenneth Offit
BLM heterozygosity and the risk of colorectal cancer.
Science (New York, N.Y.) 2002;297(5589):2013.
2002: Julie T Feldstein; J Greene; L Cohen; L Popplewell; Nathan Ellis; Kenneth Offit
Analysis of mismatch repair defects in the familial occurrence of lymphoma and colorectal cancer.
Leukemia & lymphoma 2002;43(8):1619-26.
2002: Noah D Kauff; P Perez-Segura; Mark Robson; Lauren Scheuer; B Siegel; A Schluger; Beth Rapaport; T S Frank; Khedoudja Nafa; Nathan Ellis; Giovanni Parmigiani; Kenneth Offit
Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families.
Journal of medical genetics 2002;39(8):611-4.
2002: Noah D Kauff; Jaya M Satagopan; Mark Robson; Lauren Scheuer; Martee Hensley; Clifford Hudis; Nathan Ellis; Jeff Boyd; Patrick I Borgen; Richard R Barakat; Larry Norton; Mercedes Castiel; Khedoudja Nafa; Kenneth Offit
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
The New England journal of medicine 2002;346(21):1609-15.
2002: Jaya M Satagopan; David Verbel; Venkatraman E Seshan; Kenneth Offit; Colin B Begg
Two-stage designs for gene-disease association studies.
Biometrics 2002;58(1):163-70.
2002: Lauren Scheuer; Noah D Kauff; Mark Robson; Bridget Kelly; Richard R Barakat; Jaya M Satagopan; Nathan Ellis; Martee Hensley; Jeff Boyd; Patrick I Borgen; Larry Norton; Kenneth Offit
Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1260-8.
2002: Mark Robson; Lauren Scheuer; Khedoudja Nafa; Nathan Ellis; Kenneth Offit
Unique de novo mutation of BRCA2 in a woman with early onset breast cancer.
Journal of medical genetics 2002;39(2):126-8.
2002: Nallasivam Palanisamy; Ashraf A Abou-Elella; Seeta Chaganti; Jane Houldsworth; Kenneth Offit; Diane C Louie; Julie Terayu-Feldstein; Juan C Cigudosa; Pulivarthi H Rao; Warren G Sanger; Dennis D Weisenburger; Raju S K Chaganti
Similar patterns of genomic alterations characterize primary mediastinal large-B-cell lymphoma and diffuse large-B-cell lymphoma.
Genes, chromosomes & cancer 2002;33(2):114-22.
2002: Deborah Thompson; Csilla I Szabo; Jon Mangion; Rogier A Oldenburg; Fabrice Odefrey; Sheila Seal; Rita Barfoot; Karin Kroeze-Jansema; Dawn Teare; Nazneen Rahman; Hélène Renard; Graham Mann; John L Hopper; Saundra S Buys; Irene L Andrulis; Ruby Senie; Mary B Daly; Dee West; Elaine A Ostrander; Kenneth Offit; Tamar Peretz; Ana Osorio; J Benitez; Katherine L Nathanson; Olga M Sinilnikova; Edith Olàh; Yves-Jean Bignon; Pablo Ruiz; Michael D Badzioch; Hans Vasen; Andrew P Futreal; Catherine M Phelan; steven narod; Henry T Lynch; bruce ponder; Ros A Eeles; Hanne Meijers-Heijboer; Dominique Stoppa-Lyonnet; Fergus J. Couch; Diana M Eccles; D Gareth Evans; Jenny Chang-Claude; Gilbert Lenoir; Barbara L Weber; Peter Devilee; Douglas F Easton; David E Goldgar; Michael R Stratton
Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(2):827-31.
2001: Kenneth Offit; Mark Robson; Deborah Schrag
Prophylactic mastectomy in carriers of BRCA mutations.
The New England journal of medicine 2001;345(20):1498-9; author reply 1499-500.
2001: Noah D Kauff; Lauren Scheuer; Mark Robson; Emily Glogowski; B Kelly; Richard R Barakat; Alexandra S Heerdt; Patrick I Borgen; J G Davis; Kenneth Offit
Insurance reimbursement for risk-reducing mastectomy and oophorectomy in women with BRCA1 or BRCA2 mutations.
Genetics in medicine : official journal of the American College of Medical Genetics 2001;3(6):422-5.
2001: W W Wang; Amanda B Spurdle; Prema Kolachana; Betsy Bove; Baruch Modan; Sarah Ebbers; Graeme Suthers; Margaret A Tucker; David J Kaufman; Michele Morin Doody; Robert E Tarone; Mary Daly; Hanoch Levavi; Heather Hanson Pierce; Angela Chetrit; G H Yechezkel; Georgia Chenevix-Trench; Kenneth Offit; Andrew K Godwin; Jeffery Struewing
A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(9):955-60.
2001: Jaya M Satagopan; Kenneth Offit; W Foulkes; Mark Robson; S Wacholder; C M Eng; S E Karp; Colin B Begg
The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(5):467-73.
2001: Douglas A Levine; Oscar Lin; Richard R Barakat; Mark Robson; D McDermott; L Cohen; Jaya M Satagopan; Kenneth Offit; Jeff Boyd
Risk of endometrial carcinoma associated with BRCA mutation.
Gynecologic oncology 2001;80(3):395-8.
2000: Kenneth Offit
Are BRCA1- and BRCA2-associated breast cancers different?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(21 Suppl):104S-6S.
2000: Richard R Barakat; Mark G Federici; Patricia E Saigo; Mark Robson; Kenneth Offit; Jeff Boyd
Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes.
Cancer 2000;89(2):383-90.
2000: Mary B Daly; Kenneth Offit; Frederick P Li; Gord Glendon; A Yaker; D West; B Koenig; M McCredie; Vickie Venne; S Nayfield; Daniela Seminara
Participation in the cooperative family registry for breast cancer studies: issues of informed consent.
Journal of the National Cancer Institute 2000;92(6):452-6.
2000: Kenneth Offit
Genetic prognostic markers for colorectal cancer.
The New England journal of medicine 2000;342(2):124-5.
1999: Mark Robson; D Levin; Mark G Federici; Jaya M Satagopan; F Bogolminy; Alexandra S Heerdt; Patrick I Borgen; Beryl Mc Cormick; Clifford Hudis; Larry Norton; Jeff Boyd; Kenneth Offit
Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations.
Journal of the National Cancer Institute 1999;91(24):2112-7.
1999: Boris Pasche; Prema Kolachana; Khedoudja Nafa; Jaya M Satagopan; YG Chen; RS Lo; D Brener; D Yang; L Kirstein; Carole Oddoux; Harry Ostrer; Paolo Vineis; L Varesco; Suresh C Jhanwar; Lucio Luzzatto; Joan Massagué; Kenneth Offit
TbetaR-I(6A) is a candidate tumor susceptibility allele.
Cancer research 1999;59(22):5678-82.
1998: Seeta Chaganti; Weiyi Chen; NZ Parsa; Kenneth Offit; Diane C Louie; Riccardo Dalla-Favera; Raju S K Chaganti
Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.
Genes, chromosomes & cancer 1998;23(4):323-7.
1998: Alexander Liede; Kelly A Metcalfe; Kenneth Offit; Karen T Brown; S Miller; Steven A Narod; Roxana Moslehi
A family with three germline mutations in BRCA1 and BRCA2.
Clinical genetics 1998;54(3):215-8.
1998: Mark Redston; Katherine L Nathanson; Ziqiang Yuan; Susan L Neuhausen; Jaya M Satagopan; Nora Wong; D Yang; D Nafa; JL Abrahamson; Hilmi Ozcelik; Danielle Antin-Ozerkis; Irene L Andrulis; M Daly; Leonard Pinsky; Deborah Schrag; S Gallinger; M Kaback; Mary-Claire King; T Woodage; Lawrence C Brody; A Godwin; Ellen Warner; Barbara Weber; William D Foulkes; Kenneth Offit
The APCI1307K allele and breast cancer risk.
Nature genetics 1998;20(1):13-4.
1998: E Rhei; Faina Bogomolniy; Mark G Federici; DL Maresco; Kenneth Offit; Mark Robson; Patricia E Saigo; Jeff Boyd
Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers.
Cancer research 1998;58(15):3193-6.
1998: Thomas S Frank; S A Manley; O I Olopade; S Cummings; Judy E Garber; B Bernhardt; K Antman; D Russo; M E Wood; L Mullineau; C Isaacs; Beth N Peshkin; S Buys; Vickie Venne; Peter T Rowley; Starlene Loader; Kenneth Offit; Mark Robson; H Hampel; D Brener; Eric P Winer; S Clark; B Weber; L C Strong; A Thomas
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(7):2417-25.
1998: Boris Pasche; Y Luo; Pulivarthi H Rao; Stephen D Nimer; Ethan Dmitrovsky; P Caron; Lucio Luzzatto; Kenneth Offit; Carlos Cordon-Cardo; B Renault; Jaya M Satagopan; Vundavalli Murty; Joan Massagué
Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract.
Cancer research 1998;58(13):2727-32.
1998: Pulivarthi H Rao; Jane Houldsworth; Katerina Dyomina; NZ Parsa; Juan C Cigudosa; Diane C Louie; L Popplewell; Kenneth Offit; Suresh C Jhanwar; Raju S K Chaganti
Chromosomal and gene amplification in diffuse large B-cell lymphoma.
Blood 1998;92(1):234-40.
1998: Susan L Neuhausen; A K Godwin; R Gershoni-Baruch; E Schubert; Judy E Garber; D Stoppa-Lyonnet; Edith Olah; B Csokay; OM Serova; Fiona Lalloo; A Osorio; Michael Stratton; Kenneth Offit; J Boyd; MA Caligo; R J Scott; A Schofield; E Teugels; M Schwab; Lisa A Cannon-Albright; D Timothy Bishop; Douglas Easton; J Benitez; Mary-Claire King; Bruce A J Ponder; B Weber; Peter Devilee; Ake Borg; Steven A Narod; David E Goldgar
Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.
American journal of human genetics 1998;62(6):1381-8.
1998: O I Olopade; Kenneth Offit; Judy E Garber
Genetic testing for susceptibility to cancer. Task Force on Cancer Genetics Education.
JAMA : the journal of the American Medical Association 1998;279(20):1612-3.
1998: Mark Robson; Teresa A Gilewski; B Haas; D Levin; Patrick I Borgen; P Rajan; Y Hirschaut; PI Pressman; Paul Peter Rosen; M L Lesser; Larry Norton; Kenneth Offit
BRCA-associated breast cancer in young women.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1642-9.
1998: Mark Robson; P Rajan; Paul Peter Rosen; Teresa A Gilewski; Y Hirschaut; PI Pressman; B Haas; Larry Norton; Kenneth Offit
BRCA-associated breast cancer: absence of a characteristic immunophenotype.
Cancer research 1998;58(9):1839-42.
1997: R Siebert; Diane C Louie; M Lacher; A Schluger; Kenneth Offit
Familial Hodgkin's and non-Hodgkin's lymphoma: different patterns in first-degree relatives.
Leukemia & lymphoma 1997;27(5-6):503-7.
1997: D Shattuck-Eidens; Arnold Oliphant; M McClure; celeste mcbride; J Gupte; Todd Rubano; Dmitry Pruss; Sean V Tavtigian; David Teng; N Adey; M Staebell; Kathi L Gumpper; R Lundstrom; Mark Hulick; M Kelly; J Holmen; B Lingenfelter; S Manley; F Fujimura; M Luce; Brian Ward; Lisa A Cannon-Albright; L Steele; Kenneth Offit; A Thomas
BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.
JAMA : the journal of the American Medical Association 1997;278(15):1242-50.
1997: Paul B Jacobsen; H B Valdimarsdottier; K L Brown; Kenneth Offit
Decision-making about genetic testing among women at familial risk for breast cancer.
Psychosomatic medicine 1997;59(5):459-66.
1997: SJ Laken; Gloria M Petersen; Stephen B Gruber; Carole Oddoux; Harry Ostrer; Francis M Giardiello; Stanley R Hamilton; H Hampel; Arnold J Markowitz; David S Klimstra; Suresh C Jhanwar; Sidney J Winawer; Kenneth Offit; MC Luce; Kenneth W Kinzler; Bert Vogelstein
Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC.
Nature genetics 1997;17(1):79-83.
1997: Judy E Garber; Kenneth Offit; O I Funmi Olopade; Diane Fink; Avi Barbasch; Patricia Barr; Robert K Gleeson; Barbara Le Stage
The American Society of Clinical Oncology position on genetic testing: implications for health care providers: workshop no. 4.
Cancer 1997;80(3 Suppl):632-4.
1997: Mark Robson; Kenneth Offit
New BRCA2 mutation in an Ashkenazi Jewish family with breast and ovarian cancer.
Lancet 1997;350(9071):117-8.
1997: Wylie Burke; M Daly; Judy E Garber; Jeffrey R Botkin; MJ Kahn; P Lynch; Anne McTiernan; Kenneth Offit; J Perlman; G Petersen; Elizabeth Thomson; C Varricchio
Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.
JAMA : the journal of the American Medical Association 1997;277(12):997-1003.
1997: Wylie Burke; G Petersen; P Lynch; Jeffrey R Botkin; M Daly; Judy E Garber; MJ Kahn; Anne McTiernan; Kenneth Offit; Elizabeth Thomson; C Varricchio
Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium.
JAMA : the journal of the American Medical Association 1997;277(11):915-9.
1997: Mark Robson; MK Dabney; G Rosenthal; S Ludwig; M H Seltzer; Teresa A Gilewski; B Haas; M Osborne; Larry Norton; F Gilbert; Kenneth Offit
Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer.
Genetic testing 1997;1(1):47-51.
1996: Patricia N Tonin; Barbara Weber; Kenneth Offit; Fergus J. Couch; Timothy R Rebbeck; Susan L Neuhausen; A K Godwin; Mary Daly; J Wagner-Costalos; D Berman; G Grana; E Fox; Michael F Kane; R D Kolodner; michael krainer; Daniel A Haber; Jeffery Struewing; Ellen Warner; B Rosen; Caryn Lerman; Beth N Peshkin; Larry Norton; OM Serova; William D Foulkes; Judy E Garber
Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families.
Nature medicine 1996;2(11):1179-83.
1996: Carole Oddoux; Jeffery Struewing; C M Clayton; Susan L Neuhausen; Lawrence C Brody; M Kaback; B Haas; Larry Norton; Patrick I Borgen; Suresh C Jhanwar; David E Goldgar; Harry Ostrer; Kenneth Offit
The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.
Nature genetics 1996;14(2):188-90.
1996: Kenneth Offit; Teresa A Gilewski; P McGuire; A Schluger; H Hampel; Karen T Brown; Jeff Swensen; Susan L Neuhausen; M Skolnick; Larry Norton; David E Goldgar
Germline BRCA1 185delAG mutations in Jewish women with breast cancer.
Lancet 1996;347(9016):1643-5.
1996: David Teng; R Bogden; J Mitchell; M Baumgard; R Bell; S Berry; T Davis; P C Ha; R Kehrer; S Jammulapati; Q Chen; Kenneth Offit; Mark H Skolnick; Sean V Tavtigian; Suresh C Jhanwar; B Swedlund; AK Wong; Alexander Kamb
Low incidence of BRCA2 mutations in breast carcinoma and other cancers.
Nature genetics 1996;13(2):241-4.
1996: Kenneth Offit
Breast cancer and BRCA1 mutations.
The New England journal of medicine 1996;334(18):1197-8; author reply 1199-1200.
1996: Susan L Neuhausen; Teresa A Gilewski; Larry Norton; T Tran; P McGuire; Jeff Swensen; H Hampel; Patrick I Borgen; Karen T Brown; M Skolnick; D Shattuck-Eidens; Suresh C Jhanwar; David E Goldgar; Kenneth Offit
Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.
Nature genetics 1996;13(1):126-8.
1996: Sean V Tavtigian; Jacques Simard; Johanna M Rommens; Fergus J. Couch; D Shattuck-Eidens; Susan L Neuhausen; Sofia D Merajver; Steinunn Thorlacius; Kenneth Offit; D Stoppa-Lyonnet; Carole Belanger; R Bell; S Berry; R Bogden; Q Chen; T Davis; M Dumont; Cynthia Frye; T Hattier; S Jammulapati; T Janecki; P Jiang; R Kehrer; J F Leblanc; J T Mitchell; J McArthur-Morrison; K Nguyen; Y Peng; C Samson; M Schroeder; S C Snyder; L Steele; M Stringfellow; C Stroup; B Swedlund; J Swense; David Teng; A Thomas; T Tran; M Tranchant; J Weaver-Feldhaus; AK Wong; H Shizuya; J E Eyfjord; Lisa A Cannon-Albright; M Tranchant; Fernand Labrie; Mark H Skolnick; B Weber; Alexander Kamb; David E Goldgar
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.
Nature genetics 1996;12(3):333-7.
1996: Kenneth Offit
BRCA1. A new marker in the management of patients with breast cancer?
Cancer 1996;77(4):599-601.
1996: Susan L Neuhausen; Sylvie Mazoyer; L Friedman; Michael Stratton; Kenneth Offit; A Caligo; Gail Tomlinson; Lisa A Cannon-Albright; D Timothy Bishop; D Kelsell; E Solomon; B Weber; Fergus J. Couch; Jeffery Struewing; Patricia N Tonin; Francine Durocher; Steven A Narod; Mark H Skolnick; G Lenoir; OM Serova; Bruce A J Ponder; D Stoppa-Lyonnet; Douglas Easton; Mary-Claire King; David E Goldgar
Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.
American journal of human genetics 1996;58(2):271-80.
1996: Riccardo Dalla-Favera; B H Ye; Giorgio Cattoretti; Francesco Lo Coco; Chung-Che Chang; J Zhang; Anna Migliazza; K Cechova; Huifeng Niu; Seeta Chaganti; Weiyi Chen; Diane C Louie; Kenneth Offit; Raju S K Chaganti
BCL-6 in diffuse large-cell lymphomas.
Important advances in oncology 1996;():139-48.
1996: Jane Houldsworth; S Mathew; Pulivarthi H Rao; K Dyomina; Diane C Louie; NZ Parsa; Kenneth Offit; Raju S K Chaganti
REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma.
Blood 1996;87(1):25-9.
1995: Anna Migliazza; Stefano Martinotti; Weiyi Chen; C Fusco; B H Ye; Daniel M Knowles; Kenneth Offit; Raju S K Chaganti; Riccardo Dalla-Favera
Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(26):12520-4.
1995: Kenneth Offit; Diane C Louie; NZ Parsa; P Roy; Denis Leung; Francesco Lo Coco; Andrew D Zelenetz; Riccardo Dalla-Favera; Raju S K Chaganti
BCL6 gene rearrangement and other cytogenetic abnormalities in diffuse large cell lymphoma.
Leukemia & lymphoma 1995;20(1-2):85-9.
1995: Diane C Louie; Kenneth Offit; R Jaslow; NZ Parsa; Vundavalli Murty; A Schluger; Raju S K Chaganti
p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32).
Blood 1995;86(8):2892-9.
1995: Kenneth Offit; Diane C Louie; NZ Parsa; Ariela Noy; Raju S K Chaganti
Del (7)(q32) is associated with a subset of small lymphocytic lymphoma with plasmacytoid features.
Blood 1995;86(6):2365-70.
1995: Giorgio Cattoretti; Chung-Che Chang; K Cechova; J Zhang; B H Ye; B Falini; Diane C Louie; Kenneth Offit; Raju S K Chaganti; Riccardo Dalla-Favera
BCL-6 protein is expressed in germinal-center B cells.
Blood 1995;86(1):45-53.
1995: R Siebert; Suresh C Jhanwar; Karen T Brown; Ellin Berman; Kenneth Offit
Familial acute myeloid leukemia and DiGuglielmo syndrome.
Leukemia 1995;9(6):1091-4.
1995: B H Ye; Francesco Lo Coco; Chung-Che Chang; J Zhang; Anna Migliazza; K Cechova; Daniel M Knowles; Kenneth Offit; Raju S K Chaganti; Riccardo Dalla-Favera
Alterations of the BCL-6 gene in diffuse large-cell lymphoma.
Current topics in microbiology and immunology 1995;194():101-8.
1994: Kenneth Offit; Karen T Brown
Quantitating familial cancer risk: a resource for clinical oncologists.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(8):1724-36.
1994: Kenneth Offit; Francesco Lo Coco; Diane C Louie; NZ Parsa; Denis Leung; Carol S Portlock; B H Ye; F Lista; Daniel A Filippa; A Rosenbaum
Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma.
The New England journal of medicine 1994;331(2):74-80.
1994: Kenneth Offit; Diane C Louie; NZ Parsa; Daniel A Filippa; M Gangi; R Siebert; Raju S K Chaganti
Clinical and morphologic features of B-cell small lymphocytic lymphoma with del(6)(q21q23).
Blood 1994;83(9):2611-8.
1994: Francesco Lo Coco; B H Ye; F Lista; Paolo Corradini; Kenneth Offit; Daniel M Knowles; Raju S K Chaganti; Riccardo Dalla-Favera
Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma.
Blood 1994;83(7):1757-9.
1994: Riccardo Dalla-Favera; B H Ye; Francesco Lo Coco; Gianluca Gaidano; F Lista; Daniel M Knowles; Diane C Louie; Kenneth Offit; Raju S K Chaganti
Identification of genetic lesions associated with diffuse large-cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 1():55-60.
1993: B H Ye; F Lista; Francesco Lo Coco; Daniel M Knowles; Kenneth Offit; Raju S K Chaganti; Riccardo Dalla-Favera
Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma.
Science (New York, N.Y.) 1993;262(5134):747-50.
1993: Francesco Lo Coco; Gianluca Gaidano; Diane C Louie; Kenneth Offit; Raju S K Chaganti; Riccardo Dalla-Favera
p53 mutations are associated with histologic transformation of follicular lymphoma.
Blood 1993;82(8):2289-95.
1993: Kenneth Offit; NZ Parsa; Gianluca Gaidano; Daniel A Filippa; Diane C Louie; D Pan; Suresh C Jhanwar; Govind Bhagat; Raju S K Chaganti
6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma.
Blood 1993;82(7):2157-62.
1993: Kenneth Offit; NZ Parsa; Suresh C Jhanwar; Daniel A Filippa; M Wachtel; Raju S K Chaganti
Clusters of chromosome 9 aberrations are associated with clinico-pathologic subsets of non-Hodgkin's lymphoma.
Genes, chromosomes & cancer 1993;7(1):1-7.
1992: Kenneth Offit; NZ Parsa; Daniel A Filippa; Suresh C Jhanwar; Raju S K Chaganti
t(9;14)(p13;q32) denotes a subset of low-grade non-Hodgkin's lymphoma with plasmacytoid differentiation.
Blood 1992;80(10):2594-9.
1992: Gianluca Gaidano; RS Hauptschein; NZ Parsa; Kenneth Offit; Pulivarthi H Rao; G Lenoir; Daniel M Knowles; Raju S K Chaganti; Riccardo Dalla-Favera
Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma.
Blood 1992;80(7):1781-7.
1992: Kenneth Offit
Chromosome analysis in the management of patients with non-Hodgkin's lymphoma.
Leukemia & lymphoma 1992;7(4):275-82.
1992: Marc Ladanyi; Kenneth Offit; NZ Parsa; Michael Condon; N Chekka; J P Murphy; Daniel A Filippa; Suresh C Jhanwar; Govind Bhagat; Raju S K Chaganti
Follicular lymphoma with t(8;14)(q24;q32): a distinct clinical and molecular subset of t(8;14)-bearing lymphomas.
Blood 1992;79(8):2124-30.
1992: Marc Ladanyi; Kenneth Offit; Raju S K Chaganti
Variant t(8;14) translocations in non-Burkitt's non-Hodgkin's lymphomas.
Blood 1992;79(5):1377-9.
1991: Kenneth Offit; Raju S K Chaganti
Chromosomal aberrations in non-Hodgkin's lymphoma. Biologic and clinical correlations.
Hematology/oncology clinics of North America 1991;5(5):853-69.
1991: Marc Ladanyi; NZ Parsa; Kenneth Offit; M S Wachtel; Daniel A Filippa; Suresh C Jhanwar
Clonal cytogenetic abnormalities in Hodgkin's disease.
Genes, chromosomes & cancer 1991;3(4):294-9.
1991: Kenneth Offit; Suresh C Jhanwar; Marc Ladanyi; Daniel A Filippa; Raju S K Chaganti
Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment.
Genes, chromosomes & cancer 1991;3(3):189-201.
1991: Kenneth Offit; G Wong; Daniel A Filippa; Y Tao; Raju S K Chaganti
Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations.
Blood 1991;77(7):1508-15.
1991: David J Straus; G Y Wong; J Liu; J Oppenberg; Daniel A Filippa; Jonathan Gold; Kenneth Offit; Bayard Clarkson
Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt's type) in American adults: results with treatment designed for acute lymphoblastic leukemia.
The American journal of medicine 1991;90(3):328-37.
1991: Marc Ladanyi; Kenneth Offit; Suresh C Jhanwar; Daniel A Filippa; Raju S K Chaganti
MYC rearrangement and translocations involving band 8q24 in diffuse large cell lymphomas.
Blood 1991;77(5):1057-63.
1991: P R Koduru; Kenneth Offit
Molecular structure of double reciprocal translocations: significance in B-cell lymphomagenesis.
Oncogene 1991;6(1):145-8.
1990: Kenneth Offit; Marc Ladanyi; M D Gangi; S A Ebrahim; Daniel A Filippa; Raju S K Chaganti
Ki-1 antigen expression defines a favorable clinical subset of non-B cell non-Hodgkin's lymphoma.
Leukemia 1990;4(9):625-30.
1990: S A Ebrahim; Marc Ladanyi; S B Desai; Kenneth Offit; Suresh C Jhanwar; Daniel A Filippa; P H Lieberman; Raju S K Chaganti
Immunohistochemical, molecular, and cytogenetic analysis of a consecutive series of 20 peripheral T-cell lymphomas and lymphomas of uncertain lineage, including 12 Ki-1 positive lymphomas.
Genes, chromosomes & cancer 1990;2(1):27-35.
1990: Kenneth Offit; J P Burns; I Cunningham; Suresh C Jhanwar; P Black; Nancy A Kernan; Richard J O'Reilly; Raju S K Chaganti
Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation.
Blood 1990;75(6):1346-55.
1989: Kenneth Offit; Suresh C Jhanwar; S A Ebrahim; Daniel A Filippa; Bayard Clarkson; Raju S K Chaganti
t(3;22)(q27;q11): a novel translocation associated with diffuse non-Hodgkin's lymphoma.
Blood 1989;74(6):1876-9.
1989: P R Koduru; Kenneth Offit; Daniel A Filippa; P H Lieberman; Suresh C Jhanwar
Cytogenetic and molecular genetic analysis of abnormal cells in Hodgkin's disease.
Cancer genetics and cytogenetics 1989;43(1):109-18.
1989: Raju S K Chaganti; Marc Ladanyi; F Samaniego; Kenneth Offit; Victor E Reuter; Suresh C Jhanwar; George J Bosl
Leukemic differentiation of a mediastinal germ cell tumor.
Genes, chromosomes & cancer 1989;1(1):83-7.
1989: P R Koduru; Kenneth Offit; Daniel A Filippa
Molecular analysis of breaks in BCL-1 proto-oncogene in B-cell lymphomas with abnormalities of 11q13.
Oncogene 1989;4(7):929-34.
1989: P R Koduru; Kenneth Offit; Suresh C Jhanwar
Molecular analysis of structural chromosome changes affecting chromosome band 11q23.
Disease markers 1989;7(3):145-52.
1989: Kenneth Offit; P R Koduru; R Hollis; Daniel A Filippa; Suresh C Jhanwar; Bayard Clarkson; Raju S K Chaganti
18q21 rearrangement in diffuse large cell lymphoma: incidence and clinical significance.
British journal of haematology 1989;72(2):178-83.
1989: Kenneth Offit; M E Richardson; Q Q Ceng; A Hampton; P R Koduru; Suresh C Jhanwar; Daniel A Filippa; P H Lieberman; Bayard Clarkson; Raju S K Chaganti
Nonrandom chromosomal aberrations are associated with sites of tissue involvement in non-Hodgkin's lymphoma.
Cancer genetics and cytogenetics 1989;37(1):85-93.
1987: M E Richardson; Q G Chen; Daniel A Filippa; Kenneth Offit; A Hampton; P R Koduru; Suresh C Jhanwar; P H Lieberman; Bayard Clarkson; Raju S K Chaganti
Intermediate- to high-grade histology of lymphomas carrying t(14;18) is associated with additional nonrandom chromosome changes.
Blood 1987;70(2):444-7.
1986: Kenneth Offit; N T Macris; J A Finkbeiner
Monoclonal hypergammaglobulinemia without malignant transformation in angioimmunoblastic lymphadenopathy with dysproteinemia.
The American journal of medicine 1986;80(2):292-4.
1986: Kenneth Offit; N T Macris; G Hellman; H Z Rotterdam
Consecutive lymphoma with monoclonal gammopathy in a married couple.
Cancer 1986;57(2):277-81.
1985: R W Shafer; Kenneth Offit; N T Macris; G M Horbar; L Ancona; I R Hoffman
Possible risk of steroid administration in patients at risk for AIDS.
Lancet 1985;1(8434):934-5.
1985: Kenneth Offit; N T Macris
Arsenic-associated angioimmunoblastic lymphadenopathy.
Lancet 1985;1(8422):220.